Library / Laws / 114th Congress / House Bills / H.R. 2443
H.R. 2443
To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2015-05-19 | 1.2K | ⠃⠗⠋ |